Calogero Saieva

Dr. Calogero Saieva

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
LLLorenzo Livi
Lorenzo Livi
IMIcro Meattini
Icro Meattini
LMLivia Marrazzo
Livia Marrazzo
GSGabriele Simontacchi
Gabriele Simontacchi
SPstefania pallotta
stefania pallotta
SBSimonetta Bianchi
Simonetta Bianchi

1 February 2009 in European Journal of Cancer
Verified
Journal Article
Closed access
MDMariarosaria D’eRrico
Mariarosaria D’eRrico
EREmanuele de Rinaldis
Emanuele de Rinaldis
MBMonica F. Blasi
Monica F. Blasi
VVValentina Viti
Valentina Viti
MFMario Falchetti
Mario Falchetti
EDEugenia Dogliotti
Eugenia Dogliotti

14 August 2017 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CLCamille Lassale
Camille Lassale
ITIoanna Tzoulaki
Ioanna Tzoulaki
KMKarel G M Moons
Karel G M Moons
MSMichael Sweeting
Michael Sweeting
JBJolanda Boer
Jolanda Boer
ABAdam S Butterworth
Adam S Butterworth
The hypothesis of ‘metabolically healthy obesity’ implies that, in the absence of metabolic dysfunction, individuals with excess adiposity are not at greater cardiovascular risk. We tested this hypothesis in a large pan-European prospective study. We conducted a case-cohort analysis in the 520 000-person European Prospective Investigation into Cancer and Nutrition study (‘EPIC-CVD’). During a median follow-up of 12.2 years, we recorded 7637 incident coronary heart disease (CHD) cases. Using cut-offs recommended by guidelines, we defined obesity and overweight using body mass index (BMI), and metabolic dysfunction (‘unhealthy’) as ≥ 3 of elevated blood pressure, hypertriglyceridaemia, low HDL-cholesterol, hyperglycaemia, and elevated waist circumference. We calculated hazard ratios (HRs) and 95% confidence intervals (95% CI) within each country using Prentice-weighted Cox proportional hazard regressions, accounting for age, sex, centre, education, smoking, diet, and physical activity. Compared with metabolically healthy normal weight people (reference), HRs were 2.15 (95% CI: 1.79; 2.57) for unhealthy normal weight, 2.33 (1.97; 2.76) for unhealthy overweight, and 2.54 (2.21; 2.92) for unhealthy obese people. Compared with the reference group, HRs were 1.26 (1.14; 1.40) and 1.28 (1.03; 1.58) for metabolically healthy overweight and obese people, respectively. These results were robust to various sensitivity analyses. Irrespective of BMI, metabolically unhealthy individuals had higher CHD risk than their healthy counterparts. Conversely, irrespective of metabolic health, overweight and obese people had higher CHD risk than lean people. These findings challenge the concept of ‘metabolically healthy obesity’, encouraging population-wide strategies to tackle obesity.

29 March 2006 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
PJPaula Jakszyn
Paula Jakszyn
SBSheila Bingham
Sheila Bingham
GPGuillem Pera
Guillem Pera
AAAntonio Agudo
Antonio Agudo
RLRobert Luben
Robert Luben
CGCarlos A. Gonzalez
Carlos A. Gonzalez
The risk of gastric cancer (GC) associated with dietary intake of nitrosodimethylamine (NDMA) and endogenous formation of nitroso compounds (NOCs) was investigated in the European Prospective Investigation into Cancer and Nutrition (EPIC). The study included 521 457 individuals and 314 incident cases of GC that had occurred after 6.6 average years of follow-up. An index of endogenous NOC (ENOC) formation was estimated using data of the iron content from meat intake and faecal apparent total NOC formation according to previous published studies. Antibodies to Helicobacter pylori and vitamin C levels were measured in a sub-sample of cases and matched controls included in a nested case–control within the cohort. Exposure to NDMA was <1 μg on average compared with 93 μg on average from ENOC. There was no association between NDMA intake and GC risk (HR, 1.00; 95% CI, 0.7–1.43). ENOC was significantly associated with non-cardia cancer risk (HR, 1.42; 95% CI, 1.14–1.78 for an increase of 40 μg/day) but not with cardia cancer (HR, 0.96; 95% CI, 0.69–1.33). Although the number of not infected cases is low, our data suggest a possible interaction between ENOC and H.pylori infection ( P for interaction = 0.09). Moreover, we observed an interaction between plasma vitamin C and ENOC ( P < 0.02). ENOC formation may account for our previously reported association between red and processed meat consumption and gastric cancer risk.

1 February 2011 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
BBBenedetta Bendinelli
Benedetta Bendinelli
GMGiovanna Masala
Giovanna Masala
CSCalogero Saieva
Calogero Saieva
SSSimonetta Salvini
Simonetta Salvini
CCCarmela Calonico
Carmela Calonico
SPSalvatore Panico
Salvatore Panico
Background: Many observational studies support the recommendation to eat sufficient amounts of fruit and vegetables as part of a healthy diet.Objecti

5 May 1999 in JAMA
Verified
Journal Article
Closed access
DPDomenico PALLI
Domenico PALLI
ARAntonio Giampiero Russo
Antonio Giampiero Russo
CSCalogero Saieva
Calogero Saieva
SCStefano Ciatto
Stefano Ciatto
MTMarco Rosselli Del Turco
Marco Rosselli Del Turco
PPPaolo Pacini
Paolo Pacini